MRI biomarkers of primary CNS lymphoma outcome after MATRix: real world performance - Top-Institutions - MDSpire

MRI biomarkers of primary CNS lymphoma outcome after MATRix: real world performance

  • By

  • Nitin Menon

  • Isabelle Naylor

  • Emmanuel Buba

  • Alberto Schena

  • Paul S. Morgan

  • Christopher P. Fox

  • Stefanie Thust

  • June 25, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    UK Health Research Authority
    UK Health Research Authority

    London, England

    Key Differentiators

    • Oncology

  • #2

    UK East Midlands Radiology Consortium (EMRAD)
    UK East Midlands Radiology Consortium (EMRAD)

    Nottingham, England

    Key Differentiators

    • Radiology
    • Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

Original Source(s)

MRI biomarkers of primary CNS lymphoma outcome after MATRix: real world performance

  • by Nitin Menon, Isabelle Naylor, Emmanuel Buba, Alberto Schena, Paul S. Morgan, Christopher P. Fox, Stefanie Thust

  • June 25, 2026

Related Content

Gitogenin impedes tumorigenesis in hepatocellular carcinoma via NUAK2/NF-κB axis

Current issues in clinical staging of perihilar cholangiocarcinoma—a European snapshot survey

Combined immunohistochemistry and FISH testing for diagnosing metaplastic thymoma: a case report of misdiagnosis as pulmonary mucinous epidermoid carcinoma